Single Anastomosis Duodeno-Ileostomy with Sleeve Gastrectomy/Single Anastomosis Duodenal Switch (SADI-S/SADS) IFSO Position Statement—Update 2023

IF 2.9 3区医学 Q1 SURGERY

Obesity Surgery Pub Date : 2024-09-12 DOI:10.1007/s11695-024-07490-0

Guillermo Ponce de Leon-Ballesteros, Gustavo Romero-Velez, Kelvin Higa, Jacques Himpens, Mary O’ Kane, Antonio Torres, Gerhard Prager, Miguel F. Herrera

{"title":"Single Anastomosis Duodeno-Ileostomy with Sleeve Gastrectomy/Single Anastomosis Duodenal Switch (SADI-S/SADS) IFSO Position Statement—Update 2023","authors":"Guillermo Ponce de Leon-Ballesteros, Gustavo Romero-Velez, Kelvin Higa, Jacques Himpens, Mary O’ Kane, Antonio Torres, Gerhard Prager, Miguel F. Herrera","doi":"10.1007/s11695-024-07490-0","DOIUrl":null,"url":null,"abstract":"<p><b>Abstract</b> The single anastomosis duodeno-ileostomy with sleeve gastrectomy/single anastomosis duodenal switch (SADI-S/SADS) has gained attention as an alternative to the traditional biliopancreatic diversion with duodenal switch (BPD-DS). In 2021, IFSO endorsed SADI-S/SADS as a safe and effective procedure, underscoring the necessity for long-term multidisciplinary care and randomized controlled trials (RCTs). A task force was established to conduct a systematic review of current evidence on SADI-S/SADS to guide clinical practice. A systematic review was conducted across three databases, focusing on studies examining SADI-S/SADS and its outcomes. A total of 93 studies were analyzed. SADI-S/SADS demonstrated efficacy in weight loss and medium-to-long-term control of type 2 diabetes mellitus (T2DM), along with positive outcomes regarding hypertension and hyperlipidemia. However, its impact on other comorbidities remains inconclusive. Frequent nutritional deficiencies were identified, particularly in fat-soluble vitamins, anemia, and hypoalbuminemia. Despite significant efforts, high-quality evidence on SADI-S/SADS remains scarce, prompting IFSO to advocate for increased registry participation, publication of long-term studies, and more RCTs. Lifelong supplementation and monitoring for nutritional deficiencies are recommended. The current position statement will be reviewed in 2 years.</p>","PeriodicalId":19460,"journal":{"name":"Obesity Surgery","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11695-024-07490-0","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract The single anastomosis duodeno-ileostomy with sleeve gastrectomy/single anastomosis duodenal switch (SADI-S/SADS) has gained attention as an alternative to the traditional biliopancreatic diversion with duodenal switch (BPD-DS). In 2021, IFSO endorsed SADI-S/SADS as a safe and effective procedure, underscoring the necessity for long-term multidisciplinary care and randomized controlled trials (RCTs). A task force was established to conduct a systematic review of current evidence on SADI-S/SADS to guide clinical practice. A systematic review was conducted across three databases, focusing on studies examining SADI-S/SADS and its outcomes. A total of 93 studies were analyzed. SADI-S/SADS demonstrated efficacy in weight loss and medium-to-long-term control of type 2 diabetes mellitus (T2DM), along with positive outcomes regarding hypertension and hyperlipidemia. However, its impact on other comorbidities remains inconclusive. Frequent nutritional deficiencies were identified, particularly in fat-soluble vitamins, anemia, and hypoalbuminemia. Despite significant efforts, high-quality evidence on SADI-S/SADS remains scarce, prompting IFSO to advocate for increased registry participation, publication of long-term studies, and more RCTs. Lifelong supplementation and monitoring for nutritional deficiencies are recommended. The current position statement will be reviewed in 2 years.

Abstract Image

查看原文本刊更多论文

单吻合器十二指肠-回肠造口术与袖状胃切除术/单吻合器十二指肠转换术（SADI-S/SADS）IFSO 立场声明--2023 年更新

摘要单吻合十二指肠回肠造口术加袖状胃切除术/单吻合十二指肠转流术（SADI-S/SADS）作为传统胆胰转流加十二指肠转流术（BPD-DS）的一种替代方法，已受到广泛关注。2021 年，IFSO 认可 SADI-S/SADS 是一种安全有效的手术，强调了长期多学科护理和随机对照试验 (RCT) 的必要性。为指导临床实践，成立了一个特别工作组，对目前有关 SADI-S/SADS 的证据进行系统性回顾。我们在三个数据库中进行了系统性综述，重点关注有关 SADI-S/SADS 及其结果的研究。共分析了 93 项研究。SADI-S/SADS在减轻体重和中长期控制2型糖尿病（T2DM）方面具有疗效，在高血压和高脂血症方面也取得了积极成果。然而，该疗法对其他合并症的影响尚无定论。研究发现，经常出现营养缺乏，尤其是脂溶性维生素、贫血和低白蛋白血症。尽管做出了巨大努力，但有关 SADI-S/SADS 的高质量证据仍然很少，这促使 IFSO 倡导更多的人参与登记、发表长期研究报告和进行更多的研究性试验。建议终身补充营养并监测营养缺乏情况。目前的立场声明将在两年后进行审查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Obesity Surgery 医学-外科

CiteScore

5.80

自引率

24.10%

发文量

567

审稿时长

3-6 weeks

期刊介绍： Obesity Surgery is the official journal of the International Federation for the Surgery of Obesity and metabolic disorders (IFSO). A journal for bariatric/metabolic surgeons, Obesity Surgery provides an international, interdisciplinary forum for communicating the latest research, surgical and laparoscopic techniques, for treatment of massive obesity and metabolic disorders. Topics covered include original research, clinical reports, current status, guidelines, historical notes, invited commentaries, letters to the editor, medicolegal issues, meeting abstracts, modern surgery/technical innovations, new concepts, reviews, scholarly presentations and opinions. Obesity Surgery benefits surgeons performing obesity/metabolic surgery, general surgeons and surgical residents, endoscopists, anesthetists, support staff, nurses, dietitians, psychiatrists, psychologists, plastic surgeons, internists including endocrinologists and diabetologists, nutritional scientists, and those dealing with eating disorders.

文献相关原料

公司名称	产品信息	采购帮参考价格